Literature DB >> 27940126

Comparative transcriptome analysis links distinct peritoneal tumor spread types, miliary and non-miliary, with putative origin, tubes and ovaries, in high grade serous ovarian cancer.

Katharina Auer1, Anna Bachmayr-Heyda1, Stefanie Aust1, Thomas W Grunt2, Dietmar Pils3.   

Abstract

High grade serous ovarian cancer (HGSOC) is characterized by extensive local, i.e. peritoneal, tumor spread, manifested in two different clinical presentations, miliary (many millet sized peritoneal implants) and non-miliary (few large exophytically growing peritoneal nodes), and an overall unfavorable outcome. HGSOC is thought to arise from fallopian tube secretory epithelial cells, via so called serous tubal intraepithelial carcinomas (STICs) but an ovarian origin was never ruled out for at least some cases. Comparative transcriptome analyses of isolated tumor cells from fresh HGSOC tissues and (immortalized) ovarian surface epithelial and fallopian tube secretory epithelial cell lines revealed a close relation between putative origin and tumor spread characteristic, i.e. miliary from tubes and non-miliary from ovaries. The latter were characterized by more mesenchymal cell characteristics, more adaptive tumor immune infiltration, and a favorable overall survival. Several molecular sub-classification systems (Crijns' overall survival signature, Yoshihara's subclasses, and a collagen-remodeling signature) seem to already indicate origin. Putative origin alone is a significant independent predictor for HGSOC outcome, validated in independent patient cohorts. Characteristics of both spread types could guide development of new targeted therapeutics, which are urgently needed.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fallopian tube secretory epithelial cells; Miliary; Non-miliary; Ovarian surface epithelial cells; Tumor origin; Tumor spread

Mesh:

Year:  2016        PMID: 27940126     DOI: 10.1016/j.canlet.2016.11.034

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  7 in total

1.  Identification of a Recurrence Gene Signature for Ovarian Cancer Prognosis by Integrating Single-Cell RNA Sequencing and Bulk Expression Datasets.

Authors:  Yongjian Zhang; Wei Huang; Dejia Chen; Yue Zhao; Fusheng Sun; Zhiqiang Wang; Ge Lou
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

2.  Absence of PD-L1 on tumor cells is associated with reduced MHC I expression and PD-L1 expression increases in recurrent serous ovarian cancer.

Authors:  Stefanie Aust; Sophie Felix; Katharina Auer; Anna Bachmayr-Heyda; Lukas Kenner; Sabine Dekan; Samuel M Meier; Christopher Gerner; Christoph Grimm; Dietmar Pils
Journal:  Sci Rep       Date:  2017-03-07       Impact factor: 4.379

3.  Clinical Significance of Organic Anion Transporting Polypeptide Gene Expression in High-Grade Serous Ovarian Cancer.

Authors:  Martin Svoboda; Felicitas Mungenast; Andreas Gleiss; Ignace Vergote; Adriaan Vanderstichele; Jalid Sehouli; Elena Braicu; Sven Mahner; Walter Jäger; Diana Mechtcheriakova; Dan Cacsire-Tong; Robert Zeillinger; Theresia Thalhammer; Dietmar Pils
Journal:  Front Pharmacol       Date:  2018-08-07       Impact factor: 5.810

4.  Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer.

Authors:  Qinglei Gao; Zongyuan Yang; Sen Xu; Xiaoting Li; Xin Yang; Ping Jin; Yi Liu; Xiaoshui Zhou; Taoran Zhang; Cheng Gong; Xiao Wei; Dan Liu; Chaoyang Sun; Gang Chen; Junbo Hu; Li Meng; Jianfeng Zhou; Kenjiro Sawada; Robert Fruscio; Thomas W Grunt; Jörg Wischhusen; Víctor Manuel Vargas-Hernández; Bhavana Pothuri; Robert L Coleman
Journal:  J Exp Med       Date:  2019-02-01       Impact factor: 14.307

5.  NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach.

Authors:  Christine Bekos; Besnik Muqaku; Sabine Dekan; Reinhard Horvat; Stephan Polterauer; Christopher Gerner; Stefanie Aust; Dietmar Pils
Journal:  Cancers (Basel)       Date:  2019-05-20       Impact factor: 6.639

6.  Two different, mutually exclusively distributed, TP53 mutations in ovarian and peritoneal tumor tissues of a serous ovarian cancer patient: indicative for tumor origin?

Authors:  Nyamdelger Sukhbaatar; Anna Bachmayr-Heyda; Katharina Auer; Stefanie Aust; Simon Deycmar; Reinhard Horvat; Dietmar Pils
Journal:  Cold Spring Harb Mol Case Stud       Date:  2017-07-05

7.  Neutrophil Extracellular Trap Formation Correlates with Favorable Overall Survival in High Grade Ovarian Cancer.

Authors:  Besnik Muqaku; Dietmar Pils; Johanna C Mader; Stefanie Aust; Andreas Mangold; Liridon Muqaku; Astrid Slany; Giorgia Del Favero; Christopher Gerner
Journal:  Cancers (Basel)       Date:  2020-02-21       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.